Search Results - "KAVANAGH, Brian D"

Hepatic Radiation Toxicity: Avoidance and Amelioration by Guha, Chandan, MD, PhD, Kavanagh, Brian D., MD, MPH

“…The refinement of radiation therapy and radioembolization techniques has led to a resurgent interest in radiation-induced liver disease (RILD). The awareness…”
Get full text

High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview by Grimm, Jimm, Marks, Lawrence B., Jackson, Andrew, Kavanagh, Brian D., Xue, Jinyu, Yorke, Ellen

Get full text

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study by Gomez, Daniel R, Dr, Blumenschein, George R, Prof, Lee, J Jack, Prof, Hernandez, Mike, MS, Ye, Rong, MS, Camidge, D Ross, Prof, Doebele, Robert C, MD, Skoulidis, Ferdinandos, MD, Gaspar, Laurie E, Prof, Gibbons, Don L, MD, Karam, Jose A, MD, Kavanagh, Brian D, Prof, Tang, Chad, MD, Komaki, Ritsuko, Prof, Louie, Alexander V, MD, Palma, David A, MD, Tsao, Anne S, MD, Sepesi, Boris, MD, William, William N, MD, Zhang, Jianjun, MD, Shi, Qiuling, PhD, Wang, Xin Shelley, MD, Swisher, Stephen G, Prof, Heymach, John V, Prof

“…Summary Background Evidence from retrospective studies suggests that disease progression after first-line chemotherapy for metastatic non-small-cell lung…”
Get full text

Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib by Gan, Gregory N., MD, PhD, Weickhardt, Andrew J., MBBS, DMedSc, Scheier, Benjamin, MD, Doebele, Robert C., MD, PhD, Gaspar, Laurie E., MD, MBA, Kavanagh, Brian D., MD, MPH, Camidge, D. Ross, MD, PhD

“…Purpose To analyze the durability and toxicity of radiotherapeutic local ablative therapy (LAT) applied to extra-central nervous system (eCNS) disease…”
Get full text

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis by Magnuson, William J, Lester-Coll, Nataniel H, Wu, Abraham J, Yang, T Jonathan, Lockney, Natalie A, Gerber, Naamit K, Beal, Kathryn, Amini, Arya, Patil, Tejas, Kavanagh, Brian D, Camidge, D Ross, Braunstein, Steven E, Boreta, Lauren C, Balasubramanian, Suresh K, Ahluwalia, Manmeet S, Rana, Niteshkumar G, Attia, Albert, Gettinger, Scott N, Contessa, Joseph N, Yu, James B, Chiang, Veronica L

“…Purpose Stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) are…”
Get full text

Radiation Dose–Volume Effects in the Stomach and Small Bowel by Kavanagh, Brian D., M.D., M.P.H, Pan, Charlie C., MD, Dawson, Laura A., M.D, Das, Shiva K., Ph.D, Li, X. Allen, Ph.D, Ten Haken, Randall K., Ph.D, Miften, Moyed, Ph.D

“…Published data suggest that the risk of moderately severe (≥Grade 3) radiation-induced acute small-bowel toxicity can be predicted with a threshold model…”
Get full text

Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer by Weickhardt, Andrew J, Scheier, Benjamin, Burke, Joseph Malachy, Gan, Gregory, Lu, Xian, Bunn, Jr, Paul A, Aisner, Dara L, Gaspar, Laurie E, Kavanagh, Brian D, Doebele, Robert C, Camidge, D Ross

“…Many patients with oncogene-driven non-small-cell lung cancer (NSCLC) treated with tyrosine kinase inhibitors experience limited sites of disease progression…”
Get more information

Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer by Stokes, William A, Bronsert, Michael R, Meguid, Robert A, Blum, Matthew G, Jones, Bernard L, Koshy, Matthew, Sher, David J, Louie, Alexander V, Palma, David A, Senan, Suresh, Gaspar, Laurie E, Kavanagh, Brian D, Rusthoven, Chad G

“…Purpose In early-stage non-small cell lung cancer (NSCLC), post-treatment mortality may influence the comparative effectiveness of surgery and stereotactic…”
Get full text

Radiation-Associated Liver Injury by Pan, Charlie C., M.D, Kavanagh, Brian D., M.D., M.P.H, Dawson, Laura A., M.D, Li, X. Allen, Ph.D, Das, Shiva K., Ph.D, Miften, Moyed, Ph.D, Ten Haken, Randall K., Ph.D

“…The liver is a critically important organ that has numerous functions including the production of bile, metabolism of ingested nutrients, elimination of many…”
Get full text

Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement by Guckenberger, Matthias, Belka, Claus, Bezjak, Andrea, Bradley, Jeffrey, Daly, Megan E., DeRuysscher, Dirk, Dziadziuszko, Rafal, Faivre-Finn, Corinne, Flentje, Michael, Gore, Elizabeth, Higgins, Kristin A., Iyengar, Puneeth, Kavanagh, Brian D., Kumar, Sameera, Le Pechoux, Cecile, Lievens, Yolande, Lindberg, Karin, McDonald, Fiona, Ramella, Sara, Rengan, Ramesh, Ricardi, Umberto, Rimner, Andreas, Rodrigues, George B., Schild, Steven E., Senan, Suresh, Simone II, Charles B., Slotman, Ben J., Stuschke, Martin, Videtic, Greg, Widder, Joachim, Yom, Sue S., Palma, David

“…The COVID-19 pandemic has caused radiotherapy resource pressures and led to increased risks for lung cancer patients and healthcare staff. An international…”
Get full text

Predictors of Rectal Tolerance Observed in a Dose-Escalated Phase 1-2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer by Kim, D.W. Nathan, MD, PhD, Cho, L. Chinsoo, MD, Straka, Christopher, BS, Christie, Alana, MS, Lotan, Yair, MD, Pistenmaa, David, MD, Kavanagh, Brian D., MD, Nanda, Akash, MD, PhD, Kueplian, Patrick, MD, Brindle, Jeffrey, MD, Cooley, Susan, RN, Perkins, Alida, ANP, Raben, David, MD, Xie, Xian-Jin, PhD, Timmerman, Robert D., MD

“…Purpose To convey the occurrence of isolated cases of severe rectal toxicity at the highest dose level tested in 5-fraction stereotactic body radiation therapy…”
Get full text

Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trial by Hannan, Raquibul, Tumati, Vasu, Xie, Xian-Jin, Cho, L. Chinsoo, Kavanagh, Brian D, Brindle, Jeffrey, Raben, David, Nanda, Akash, Cooley, Susan, Kim, D.W. Nathan, Pistenmaa, David, Lotan, Yair, Timmerman, Robert

“…Abstract Background We report the outcome of a phase I/II clinical trial of stereotactic body radiation therapy (SBRT) for low (LR) and select intermediate…”
Get full text

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases by RUSTHOVEN, Kyle E, KAVANAGH, Brian D, GASPAR, Laurie E, SCHEFTER, Tracey E, CARDENES, Higinia, STIEBER, Volker W, BURN, Stuart H, FEIGENBERG, Steven J, CHIDEL, Mark A, PUGH, Thomas J, FRANKLIN, Wilbur, KANE, Madeleine

“…To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three hepatic…”
Get full text

Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies by Zhao, Jing, MD, PhD, Yorke, Ellen D., PhD, Li, Ling, MD, PhD, Kavanagh, Brian D., MD, Li, X. Allen, PhD, Das, Shiva, PhD, Miften, Moyed, PhD, Rimner, Andreas, MD, Campbell, Jeffrey, PhD, Xue, Jinyu, PhD, Jackson, Andrew, PhD, Grimm, Jimm, PhD, Milano, Michael T., MD, PhD, (Spring) Kong, Feng-Ming, MD, PhD

“…Purpose To study the risk factors for radiation-induced lung toxicity (RILT) after stereotactic body radiation therapy (SBRT) of the thorax. Methods and…”
Get full text

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases by RUSTHOVEN, Kyle E, KAVANAGH, Brian D, BURRI, Stuart H, CHANGHU CHEN, CARDENES, Higinia, CHIDEL, Mark A, PUGH, Thomas J, KANE, Madeleine, GASPAR, Laurie E, SCHEFTER, Tracey E

“…To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of patients with one to three lung…”
Get full text

Stereotactic Body Radiation Therapy in Multiple Organ Sites by TIMMERMAN, Robert D, KAVANAGH, Brian D, CHINSOO CHO, L, PAPIEZ, Lech, LEI XING

“…Stereotactic body radiation therapy (SBRT) uses advanced technology to deliver a potent ablative dose to deep-seated tumors in the lung, liver, spine,…”
Get full text

The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma by Jackson, Matthew W, Palma, David A, Camidge, D Ross, Jones, Bernard L, Robin, Tyler P, Sher, David J, Koshy, Matthew, Kavanagh, Brian D, Gaspar, Laurie E, Rusthoven, Chad G

“…The optimal role for postoperative radiotherapy (PORT) for thymoma and thymic carcinoma remains controversial. We used the National Cancer Data Base to…”
Get more information

Chest Wall Volume Receiving >30 Gy Predicts Risk of Severe Pain and/or Rib Fracture After Lung Stereotactic Body Radiotherapy by Dunlap, Neal E., M.D, Cai, Jing, Ph.D, Biedermann, Gregory B., M.D, Yang, Wensha, Ph.D, Benedict, Stanley H., Ph.D, Sheng, Ke, Ph.D, Schefter, Tracey E., M.D, Kavanagh, Brian D., M.D, Larner, James M., M.D

“…Purpose To identify the dose–volume parameters that predict the risk of chest wall (CW) pain and/or rib fracture after lung stereotactic body radiotherapy…”
Get full text

The Impact of Definitive Local Therapy for Lymph Node-Positive Prostate Cancer: A Population-Based Study by Rusthoven, Chad G., MD, Carlson, Julie A., MD, Waxweiler, Timothy V., MD, Raben, David, MD, Dewitt, Peter E., MS, Crawford, E. David, MD, Maroni, Paul D., MD, Kavanagh, Brian D., MD

“…Purpose To evaluate the survival outcomes for patients with lymph node-positive, nonmetastatic prostate cancer undergoing definitive local therapy (radical…”
Get full text

Radiation-Associated Kidney Injury by Dawson, Laura A., M.D, Kavanagh, Brian D., M.D, Paulino, Arnold C., M.D, Das, Shiva K., Ph.D, Miften, Moyed, Ph.D, Li, X. Allen, Ph.D, Pan, Charlie, M.D, Ten Haken, Randall K., Ph.D, Schultheiss, Timothy E., Ph.D

“…The kidneys are the dose-limiting organs for radiotherapy to upper abdominal cancers and during total body irradiation. The incidence of…”
Get full text